Literature DB >> 3808607

Retinal and neurologic findings in the Laurence-Moon-Bardet-Biedl phenotype.

J F Rizzo, E L Berson, S Lessell.   

Abstract

The nosology of the Laurence-Moon and Bardet-Biedl syndromes has been controversial. Presented is a patient with polydactyly, retinopathy, ataxia, low-average intellectual function, and obesity. These features constitute a composite of both syndromes and reflect the clinical heterogeneity that may be seen. Accordingly, the authors suggest the use of the term "Laurence-Moon-Bardet-Biedl phenotype" until these syndromes can be defined in some other manner. The neuroradiologic studies document atrophy of the cerebellum that accounts for the ataxia. Electroretinograms (ERG) demonstrate the decline in retinal function over a 16-year interval and the delayed cone ERG b-wave implicit time with normal cone amplitudes to 30 Hz white flicker that can exist in the early stage of this disorder.

Entities:  

Mesh:

Year:  1986        PMID: 3808607     DOI: 10.1016/s0161-6420(86)33546-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  12 in total

1.  Intrafamilial variation of the phenotype in Bardet-Biedl syndrome.

Authors:  R Riise; S Andréasson; M K Borgaström; A F Wright; N Tommerup; T Rosenberg; K Tornqvist
Journal:  Br J Ophthalmol       Date:  1997-05       Impact factor: 4.638

2.  New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey.

Authors:  P L Beales; N Elcioglu; A S Woolf; D Parker; F A Flinter
Journal:  J Med Genet       Date:  1999-06       Impact factor: 6.318

3.  Molecular analysis of Bardet-Biedl syndrome families: report of 21 novel mutations in 10 genes.

Authors:  Jianjun Chen; Nizar Smaoui; Monia Ben Hamed Hammer; Xiaodong Jiao; S Amer Riazuddin; Shyana Harper; Nicholas Katsanis; Sheikh Riazuddin; Habiba Chaabouni; Eliot L Berson; J Fielding Hejtmancik
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-18       Impact factor: 4.799

4.  Clinical pathology and retinal vascular structure in the Bardet-Biedl syndrome.

Authors:  T Bek; T Rosenberg
Journal:  Br J Ophthalmol       Date:  1995-01       Impact factor: 4.638

5.  Pediatric renal transplantation in Laurence-Moon-Biedl syndrome.

Authors:  C M Collins; S A Mendoza; W R Griswold; D Tanney; E Lieberman; V M Reznik
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

6.  Evolution of ocular clinical and electrophysiological findings in pediatric Bardet-Biedl syndrome.

Authors:  E Spaggiari; R Salati; P Nicolini; R Borgatti; U Pozzoli; F Polenghi
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

Review 7.  Retinitis pigmentosa, pigmentary retinopathies, and neurologic diseases.

Authors:  M Tariq Bhatti
Journal:  Curr Neurol Neurosci Rep       Date:  2006-09       Impact factor: 5.081

8.  Phenotypic characterization of Bbs4 null mice reveals age-dependent penetrance and variable expressivity.

Authors:  Erica R Eichers; Muhammad M Abd-El-Barr; Richard Paylor; Richard Alan Lewis; Weimin Bi; Xiaodi Lin; Thomas P Meehan; David W Stockton; Samuel M Wu; Elizabeth Lindsay; Monica J Justice; Philip L Beales; Nicholas Katsanis; James R Lupski
Journal:  Hum Genet       Date:  2006-06-23       Impact factor: 4.132

9.  Brain tissue- and region-specific abnormalities on volumetric MRI scans in 21 patients with Bardet-Biedl syndrome (BBS).

Authors:  Kim M Keppler-Noreuil; Catherine Blumhorst; Julie C Sapp; Danielle Brinckman; Jennifer Johnston; Peggy C Nopoulos; Leslie G Biesecker
Journal:  BMC Med Genet       Date:  2011-07-27       Impact factor: 2.103

10.  Neuropathy target esterase impairments cause Oliver-McFarlane and Laurence-Moon syndromes.

Authors:  Robert B Hufnagel; Gavin Arno; Nichole D Hein; Joshua Hersheson; Megana Prasad; Yvonne Anderson; Laura A Krueger; Louise C Gregory; Corinne Stoetzel; Thomas J Jaworek; Sarah Hull; Abi Li; Vincent Plagnol; Christi M Willen; Thomas M Morgan; Cynthia A Prows; Rashmi S Hegde; Saima Riazuddin; Gregory A Grabowski; Rudy J Richardson; Klaus Dieterich; Taosheng Huang; Tamas Revesz; J P Martinez-Barbera; Robert A Sisk; Craig Jefferies; Henry Houlden; Mehul T Dattani; John K Fink; Helene Dollfus; Anthony T Moore; Zubair M Ahmed
Journal:  J Med Genet       Date:  2014-12-05       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.